Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The centre is expected to be operational in 2027 and will join Amgen’s global R...
The agreement covers US commercial and global manufacturing rights to Mereo Bio...
Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for bu...
The deal includes joint studies combining BeOne’s cancer pipeline assets with fo...
Unanimously approved by both companies’ boards, the transaction is expected to c...
Tiyo Kok Fong highlights how pharmaceutical manufacturers can integrate water m...
Paolo Carli highlights how the expansion will support analytical and biosafety ...
The healthcare industry reported 87 deals worth $29.5 billion in July 2026, whi...
Funding was 34.42% lower than the previous month and 59.71% lower than the same...
Dr Suresh R. Saravdekar highlights the need for statutory regulation, mandator...
Deal combines Amneal’s commercial scale with Kashiv’s biosimilars research, dev...
The drug is bioequivalent to AstraZeneca’s Lokelma and indicated for hyperkalae...
The collaboration will focus on process technology transfer and activities relat...
Under the contract, Daiichi Sankyo will continue to handle development, manufact...
Investment validates Biodeal's leadership in specialty pharma manufacturing, st...
REVAHALE (Revefenacin) offers sustained 24-hour bronchodilation through conveni...